Tonix Pharmaceuticals Holding Corp. Quarterly Debt-to-equity in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Tonix Pharmaceuticals Holding Corp. quarterly Debt-to-equity history and growth rate from Q1 2012 to Q3 2024.
  • Tonix Pharmaceuticals Holding Corp. Debt-to-equity for the quarter ending September 30, 2024 was 37.9 %, a 244% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 37.9 +26.9 +244% Sep 30, 2024
Q2 2024 32.6 +23.8 +271% Jun 30, 2024
Q1 2024 24 +16.5 +219% Mar 31, 2024
Q4 2023 18.9 +11.5 +155% Dec 31, 2023
Q3 2023 11 +3.33 +43.3% Sep 30, 2023
Q2 2023 8.78 +0.98 +12.6% Jun 30, 2023
Q1 2023 7.5 +0.19 +2.6% Mar 31, 2023
Q4 2022 7.38 +0.95 +14.8% Dec 31, 2022
Q3 2022 7.7 +1.77 +29.9% Sep 30, 2022
Q2 2022 7.8 +1.72 +28.3% Jun 30, 2022
Q1 2022 7.31 +0.23 +3.25% Mar 31, 2022
Q4 2021 6.43 -3.38 -34.5% Dec 31, 2021
Q3 2021 5.93 -5.33 -47.4% Sep 30, 2021
Q2 2021 6.08 -8.35 -57.9% Jun 30, 2021
Q1 2021 7.08 -12.5 -63.9% Mar 31, 2021
Q4 2020 9.8 -14.2 -59.1% Dec 31, 2020
Q3 2020 11.3 -3.51 -23.8% Sep 30, 2020
Q2 2020 14.4 +0.61 +4.41% Jun 30, 2020
Q1 2020 19.6 +5.93 +43.3% Mar 31, 2020
Q4 2019 24 +10.2 +74.1% Dec 31, 2019
Q3 2019 14.8 +1.89 +14.7% Sep 30, 2019
Q2 2019 13.8 +3.71 +36.7% Jun 30, 2019
Q1 2019 13.7 +5.93 +76.4% Mar 31, 2019
Q4 2018 13.8 +6.75 +96.3% Dec 31, 2018
Q3 2018 12.9 +5.9 +84.6% Sep 30, 2018
Q2 2018 10.1 +2.27 +28.9% Jun 30, 2018
Q1 2018 7.76 -2.71 -25.9% Mar 31, 2018
Q4 2017 7.01 -4.95 -41.4% Dec 31, 2017
Q3 2017 6.97 -7.25 -51% Sep 30, 2017
Q2 2017 7.85 -5.61 -41.7% Jun 30, 2017
Q1 2017 10.5 -1.92 -15.5% Mar 31, 2017
Q4 2016 12 +1.66 +16.1% Dec 31, 2016
Q3 2016 14.2 +5.42 +61.6% Sep 30, 2016
Q2 2016 13.5 +5.11 +61.2% Jun 30, 2016
Q1 2016 12.4 +5.15 +71.2% Mar 31, 2016
Q4 2015 10.3 +3.45 +50.3% Dec 31, 2015
Q3 2015 8.8 +1.38 +18.6% Sep 30, 2015
Q2 2015 8.34 -0.47 -5.33% Jun 30, 2015
Q1 2015 7.24 -8.16 -53% Mar 31, 2015
Q4 2014 6.85 -77.4 -91.9% Dec 31, 2014
Q3 2014 7.42 -172 -95.9% Sep 30, 2014
Q2 2014 8.82 +248 Jun 30, 2014
Q1 2014 15.4 -1.12K -98.6% Mar 31, 2014
Q4 2013 84.2 -860 -91.1% Dec 31, 2013
Q3 2013 179 +451 Sep 30, 2013
Q2 2013 -239 +77 +24.4% Jun 30, 2013
Q1 2013 1.13K +1.34K Mar 31, 2013
Q4 2012 944 Dec 31, 2012
Q3 2012 -272 Sep 30, 2012
Q2 2012 -316 Jun 30, 2012
Q1 2012 -208 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.